IDEOlogy Health, a provider of non-promotional, multi-channel medical education to oncology professionals, on Tuesday announced two exclusive strategic partnership agreements with West Cancer Center & Research Institute, designed to elevate physician and Advanced Practice Provider (APP) education.
Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community.
West Cancer Center & Research Institute offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care.
By combining IDEOlogy Health's innovative educational platforms with West's clinical expertise, the collaboration aims to help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care.
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline
ZYUS Life Sciences receives second US pain management patent
Lunai Bioworks completes USD20m preferred issuance to acquire CNS delivery and neurotherapeutic IP
Photocure study supports cost-effectiveness of blue light cystoscopy
Apotex receives Health Canada approval for a generic Ozempic equivalent
Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia
Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review
FDB introduces gravimetric content to improve IV medication compounding